首页> 外文OA文献 >Untersuchung der Genexpression von ABC- und SLC-Transmembranproteinen mit Beteiligung am aktiven Transport von Antigenen, Eikosanoiden und Zytostatika beim malignen Melanom
【2h】

Untersuchung der Genexpression von ABC- und SLC-Transmembranproteinen mit Beteiligung am aktiven Transport von Antigenen, Eikosanoiden und Zytostatika beim malignen Melanom

机译:研究ABC和SLC跨膜蛋白的基因表达并参与恶性黑色素瘤中抗原,类花生酸和细胞抑制剂的主动转运

摘要

Malignant melanoma is the most aggressive form of human skin cancer. Rising incidence in the Caucasian population and disappointing results of chemotherapy at metastatic stage make melanoma a major medical challenge. The last decades have shown great progress in discovery and description of transporters that confer drug resistance or mediate inflammatory tumour response like the multidrug resistance-associated proteins (MRP), the organic anion transporting polypeptides (OATP) and transporters associated with antigen processing (TAP). It is presumed that influx transport proteins such as OATP (uptake, phase 0) interact synergistically with metabolizing enzymes such as CYP (biotransformation, phase I and II) and effluxers like MRP (anti-transport, phase III). Meanwhile, it has become clear that the MRP/OATP combination is involved in the transport not only of endo- or xenobiotics, but also of lipid mediators like prostaglandins and leukotrienes. Some MRPs and OATPs show similarities in substrate profiles and function. Coexpression in melanoma is not well known yet, but evidence suggests a coordinate activity of MRP and OATP in vectorial transmembranous substrate transfer. Little is known about the pattern of transporters in malignant melanoma. In this study, the differential mRNA expression of 18 cell lines originating from primary melanoma and metastases of malignant melanoma compared with normal human melanocytes was examined with Affymetrix microarray and consecutively confirmed by real-time PCR. High basic expression levels were detected for MRP1, MRP2, MRP4, OATP3A1 and the still functionally uncharacterized OATP5A1. We could also show a down-regulation of TAP1. TAP1 mediates antigen presentation via MHC-I. MRP can confer drug resistance by decreasing the intracellular drug concentration. One example is cisplatin resistance due to MRP2. Eicosanoid-transport is mediated by MRP4 (e.g. PGE2, LTB4), MRP1 (LTC4) and OATP3A1 (PGE2). There is growing evidence that these lipids play a key role in cell proliferation and migration. Showing the mRNA expression of efflux and influx transporters, we provide data that strongly support the functional role of MRP and OATP in drug resistance and inflammation in malignant melanoma.
机译:恶性黑色素瘤是人类皮肤癌的最具侵袭性的形式。高加索人群的发病率上升以及转移期化疗的令人失望的结果使黑素瘤成为一项重大的医学挑战。最近几十年来,在发现和描述赋予耐药性或介导炎性肿瘤反应的转运蛋白(如多药耐药相关蛋白(MRP),有机阴离子转运多肽(OATP)和与抗原加工相关的转运蛋白(TAP))的发现和描述中取得了重大进展。 。据推测,诸如OATP(摄取,第0阶段)之类的流入转运蛋白与诸如CYP(生物转化,第I和II期)之类的代谢酶和如MRP(反运输,第III期)之类的流出剂协同相互作用。同时,已经清楚的是,MRP / OATP组合不仅参与内生或异源生物的运输,而且还参与诸如前列腺素和白三烯的脂质介体的运输。一些MRP和OATP在底物特征和功能上显示出相似性。黑素瘤中的共表达尚不为人所知,但有证据表明MRP和OATP在矢量跨膜底物转移中具有协同活性。关于恶性黑色素瘤中转运蛋白的模式知之甚少。在这项研究中,使用Affymetrix芯片检查了与正常人黑色素细胞相比源自原发性黑色素瘤和恶性黑色素瘤转移的18种细胞系的差异mRNA表达,并通过实时PCR连续进行了证实。检测到MRP1,MRP2,MRP4,OATP3A1和仍未功能化的OATP5A1的高碱性表达水平。我们还可以显示TAP1的下调。 TAP1通过MHC-1介导抗原呈递。 MRP可通过降低细胞内药物浓度来赋予耐药性。一个例子是由于MRP2而引起的顺铂耐药性。类花生酸转运是由MRP4(例如PGE2,LTB4),MRP1(LTC4)和OATP3A1(PGE2)介导的。越来越多的证据表明这些脂质在细胞增殖和迁移中起关键作用。显示外排和内向转运蛋白的mRNA表达,我们提供的数据强烈支持MRP和OATP在恶性黑色素瘤的耐药性和炎症中的功能作用。

著录项

  • 作者

    Wendel Andreas Friedrich;

  • 作者单位
  • 年度 2009
  • 总页数
  • 原文格式 PDF
  • 正文语种 ger
  • 中图分类
  • 入库时间 2022-08-31 14:59:34

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号